中东和非洲减肥药市场预测至 2028 年 - COVID-19 影响和按产品类型（处方药、非处方药和草药补充剂）、应用（抑制食欲、脂肪阻断、促进新陈代谢药丸等）进行的区域分析，年龄组（儿童和成人）和分销渠道（医院药房、网上药房、零售药房和药店）
No. of Pages: 96 | Report Code: BMIRE00025190 | Category: Life Sciences
No. of Pages: 96 | Report Code: BMIRE00025190 | Category: Life Sciences
消费者高度倾向于植物-基于草药补充剂和植物药，为减肥药市场的草药补充剂供应商开辟了新的繁荣途径 。消费者对植物提取物的偏爱是由于对清洁标签产品的日益渴望以及对成分的可持续性和过敏性 的担忧。草药补充剂的目标市场正在从纯素食者转向弹性素食者 ，这表明客户偏好的转变。根据 Good Food Institute 的数据，植物性补充剂市场在 2020 年第一季度经历了销量激增。此外，超过一半的膳食补充剂消费者增加了消费量，其余超过三分之一的人计划转向2020 年第二季度转向植物性补充剂。因此，从动物蛋白到植物性蛋白的转变可能会在未来几年推动植物性补充剂市场的增长。
借助新功能和技术，供应商吸引新客户，在新兴市场扩大足迹市场。这一因素可能会推动MEA减肥药市场。 MEA 减肥药市场预计在预测期内将以复合年增长率大幅增长。
MEA减肥药市场细分
< MEA 减肥药市场按产品类型、应用、年龄组、分销渠道和国家细分。根据产品类型，MEA 减肥药市场分为处方药、草药补充剂和非处方药。 2020年处方药市场占据主导地位。根据应用，MEA减肥药市场分为抑制食欲药、阻脂药、促进新陈代谢药等。食欲抑制细分市场在 2020 年占据市场主导地位。根据年龄组，MEA 减肥药市场分为成人和青少年。成人细分市场在 2020 年占据主导地位。根据分销渠道，MEA 减肥药市场分为医院药房、网上药房、零售药房和零售药房。药店。医院药房领域在 2020 年引领市场。根据国家/地区，MEA 减肥药市场分为沙特阿拉伯、南非、阿联酋和 MEA 的其他地区。沙特阿拉伯市场在 2020 年占据主导地位。
辉瑞公司 (Arena Pharmaceutical GMBH)、诺和诺德 A/ S、GlaxoSmithKline plc、Lovate Health Sciences International Inc.、TEVA Pharmaceutical Industries LTD 和 Chong’s Health Care 是 MEA 减肥药市场的领先公司。
Strategic insights for Middle East and Africa Diet Pills involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 46.43 Million |
| Market Size by 2028 | US$ 81.98 Million |
| Global CAGR (2021 - 2028) | 8.5% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Diet Pills refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Diet Pills Market is valued at US$ 46.43 Million in 2021, it is projected to reach US$ 81.98 Million by 2028.
As per our report Middle East and Africa Diet Pills Market, the market size is valued at US$ 46.43 Million in 2021, projecting it to reach US$ 81.98 Million by 2028. This translates to a CAGR of approximately 8.5% during the forecast period.
The Middle East and Africa Diet Pills Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Diet Pills Market report:
The Middle East and Africa Diet Pills Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Diet Pills Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Diet Pills Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Diet Pills Market
